Harnessing Computational Approaches for RNA-Targeted Drug Discovery.

Area of Science:

• Biochemistry
• Computational Biology
• Medicinal Chemistry

Background:

• RNA molecules are crucial therapeutic targets due to their regulatory functions.
• Computational modeling offers a pathway to accelerate RNA-targeted drug discovery.
• Challenges include limited experimental data and modeling RNA's conformational flexibility.

Purpose of the Study:

• To review advancements in computational modeling of RNA-small molecule interactions.
• To highlight practical applications in RNA-targeted drug discovery.
• To survey existing databases for nucleic acid-small molecule interactions.

Main Methods:

• Structure-based approaches for identifying RNA-targeting compounds.
• Quantitative Structure-Activity Relationship (QSAR) models.
• Review of computational methods and databases.

Main Results:

• Successful identification of active RNA-targeting compounds using computational methods.
• Overview of current capabilities and limitations in modeling RNA-ligand interactions.
• Identification of relevant databases for RNA-small molecule interactions.

Conclusions:

• Computational modeling is vital for advancing RNA-targeted drug discovery.
• Novel models and expanded databases will drive future development.
• Improved identification of selective small-molecule modulators for therapeutic applications is anticipated.